Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in patients with chronic anaemia such as beta-thalassaemia major (beta-TM) and sickle cell disease (SCD). Data sources: Electronic data...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: C McLeod, N Fleeman, J Kirkham, A Bagust, A Boland, P Chu, R Dickson, Y Dundar, J Greenhalgh, B Modell, A Olujohungbe, P Telfer, T Walley
Format: Artigo
Langue:Inglês
Publié: NIHR Journals Library 2009-01-01
Collection:Health Technology Assessment
Sujets:
deferasirox
iron-overload
sickle-cell-disease
beta-thalassaemia
transfusionalhaemosiderosis
iron-chelating-agent
Accès en ligne:https://doi.org/10.3310/hta13010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires